Search
Satellos Bioscience Ord Shs
MSLEAdd to Watchlist
9.180USD
-0.140-1.50%
Close 09-21 16:00（ET）
192.55MMarket Cap
LossP/E TTM
MSLE Analyst Recommendation Trends
In the current month, MSLE has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MSLE average Analyst price target in the last month is 23.167.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
1
1
0
0
0
4
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
6
4
1
0
0
0
Financial Forecasting
Based on analysts' estimates, MSLE EPS is projected to reach -0.526 in FY2026Q3, following reported EPS of -0.563 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.05
-0.50
-0.53
-0.53
-0.51
Actual
-0.47
-0.53
-0.56
--
--
Surprise
-856.06%
-6.46%
-5.83%
--
--
FAQs
How have Satellos Bioscience Ord ShsMSLE's recent earnings per share performed?
The market expectation was USD -0.56, while Satellos Bioscience Ord ShsMSLE's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.53.
What is the analyst rating for Satellos Bioscience Ord Shs?
Based on the ratings of Satellos Bioscience Ord Shs's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.